Insider Profile
Bazemore, Robert Jr.
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Jun 25, 2026
Most Recent Trade
| Date | Company | Dir. | Value |
|---|---|---|---|
| Jun 25, 2026 |
$EPRX
Eupraxia Pharmaceuticals
|
Buy | $356K |
| Jun 25, 2026 |
$EPRX
Eupraxia Pharmaceuticals
|
Buy | — |
| Jun 18, 2026 |
$EPRX
Eupraxia Pharmaceuticals
|
Sell | — |
Muted rows are plan purchases, compensation grants, or DRIP — not open-market.
Confluence Scores reflect the company's current score, not the score at time of trade.